AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service
Karachi, GlaxoSmithKline Pakistan. NC (GLAXO), a significant entity in the pharmaceutical industry since 1953, maintained consistent market performance in 2023. The company’s stock traded at a high rate of Rs. 83.70 and a low rate of Rs. 84.16. With a paid-up capital of Rs. 3,184.67 million, GlaxoSmithKline Pakistan reported an EPS of Rs. 68 for the year. No distributions were announced for 2022 or 2023.
Check Also
Provision of Quality Education Foremost Priority: Mohsin Bukhari
Islamabad: Provision of quality education has been identified as the foremost priority by Professor Syed Mohsin Raza Bukhari, Deputy Director of the Directorate of Public Instruction (Colleges), Punjab. In an exclusive interview on International Liter...